Experiment 2D and 5D: Progressive Sample Scaling Algorithm To Solve Many-Affine BBOB Functions. by Boris Almonacid (4110337)

“…This process is repeated until the budget is exhausted. Optionally, there is a factor value that can increase or decrease the number of points during execution in the Scaling stage.…”

Altered spatial distribution of EPDCs in <i>Wt1</i>^Cre; <i>Sox9</i>^fl/fl; <i>R26</i>^mG hearts. by Andrew B. Harvey (21587431)

“…<b>(I)</b> Nearest-neighbor analysis reveals a decreased average distance between GFP+ object centroids and their nearest CD109 + neighbor in <i>Wt1</i>^Cre; <i>Sox9</i>^fl/fl; <i>R26</i>^mG specimens. …”

Computational optimization of the circuits for specific functions further reveals general design principles. by Xiaojing Yang (154840)

“…(C) <i>In silico</i> evolution to optimize the catalytic efficiencies of the kinases for a desired function in discrete steps of mutation and selection (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001673#pbio.1001673.s005" target="_blank">Figure S5A</a> for a detailed illustration). …”

Single-cell analysis of transcript expression during binary fate decision in EML cells. by Mitra Mojtahedi (3603509)

“…As previously reported [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2000640#pbio.2000640.ref004" target="_blank">4</a>], myeloid differentiation in EML cells is driven by the Sca1^HIGH fraction of cells and the global decrease of Sca1 expression is delayed, and can bounce back to intermediate state once cell have passed the bimodal (d3) stage. …”

Table_1_Differential regulatory T cell signature after recovery from mild COVID-19.docx by Pedro Henrique de Sousa Palmeira (14758156)

“…Moreover, Mild Recovered unstimulated samples presented a higher Tregs frequency and expression of IL-10 and granzyme B than did that of HC. …”

DataSheet_1_Differential regulatory T cell signature after recovery from mild COVID-19.pdf by Pedro Henrique de Sousa Palmeira (14758156)

“…Moreover, Mild Recovered unstimulated samples presented a higher Tregs frequency and expression of IL-10 and granzyme B than did that of HC. …”

Physiological potential of stylosanthes cv. Campo Grande seeds coated with different materials by Priscilla Brites Xavier (6117773)

Assessment of in vitro and in vivo effect of Quercetin 3-Glucoside, Oxyresveratrol and Quercetin O-Hexoside against Leishmania tropica by Kashif Iqbal (6504587)

At clinically relevant concentrations the anaesthetic/amnesic thiopental but not the anticonvulsant phenobarbital interferes with hippocampal sharp wave-ripple complexes-2 by Costas Papatheodoropoulos (78587)

“…Example of thiopental-induced prolongation of SPWs (a) at two different concentrations. Averages of low-pass filtered sweeps taken from a two minute epoch are shown. …”

Pharmacological manipulations and neuron model. by Dominique Martinez (229854)

“…The inhibitory phase was constant (p = 1, Kruskal–Wallis test): <i>I</i> duration = 399±106 ms. The neuron model (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0061220#pone.0061220.s005" target="_blank">Text S1</a>) was simulated with inputs mimicking a 1 ng pheromone blend stimulus (200, 500 or 1000 ms duration; 10 runs in each condition), resulting from fits of experimental data recorded in olfactory receptor neurons <i>in vivo </i><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0061220#pone.0061220-Jarriault1" target="_blank">[12]</a>. …”

Construction principles of the model. by Maximilian Schmidt (3712144)

“…Figure adapted from [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006359#pcbi.1006359.ref035" target="_blank">35</a>] and [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006359#pcbi.1006359.ref036" target="_blank">36</a>] (with permission). …”

Perspectives on research DTTC (Thomas et al., 2025) by Donna Thomas (12427672)

“…<i>American Journal of Speech-Language Patholog</i><i>y, </i><i>34</i>(4S), 2509–2518. <a href="https://doi.org/10.1044/2024_AJSLP-24-00228" rel="noreferrer" target="_blank">https://doi.org/10.1044/2024_AJSLP-24-00228</a></p><p dir="ltr"><b>Publisher Note:</b> This article is part of the Special Issue: Select Papers From the 2024 Conference on Motor Speech—Clinical Science and Implications.…”

Spike inference applied to Pavlovian conditioning <i>in vivo</i> imaging data recapitulates transient cue responses, pauses following reward omission, and previously reported relat... by Weston Fleming (10924744)

“…Neurons that exhibited a significant decrease in firing following reward omission (22/65 neurons; 33.9% of population) are darker green. …”

Daily voice use of patients with NPVH (Van Stan et al., 2021) by Jarrad H. Van Stan (9722275)

“…D., Burns, J. A., Hron, T., Stadelman-Cohen, T., Krusemark, C., Muise, J., Fox-Galalis, A. …”

Application to actual brain network functional states. by Remy Ben Messaoud (20521877)

“…Input control signals are obtained solving <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012691#pcbi.1012691.e018" target="_blank">Eq 3</a> using the parameters <i>t</i>_<i>f</i> = 1, <i>dτ =</i> 0.01, and <i>ρ =</i> 0.0043, 0.0121, 0.0234 respectively for one, eight and 64 drivers. …”

Image8_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”

Table1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.XLSX by Irina Zakharova (766005)

“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”

Image4_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”

Image3_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”

Image5_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”